Overview

Galantamine in the Treatment of Post-Traumatic Headache

Status:
Unknown status
Trial end date:
2005-08-01
Target enrollment:
Participant gender:
Summary
Most patients with CPTH present with additional major cognitive, behavioral and somatic problems. Most drugs used currently have a negative influence on cognition. Therefore, treatment strategies addressing both the headache and cognitive disturbances in patients with CPTH are necessary. (CPTH; Chronic Post Traumatic Headache).
Phase:
Phase 4
Details
Lead Sponsor:
Rapoport, Alan, M.D.
Collaborator:
Ortho-McNeil Neurologics, Inc.
Treatments:
Galantamine